Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fendo.2026.1783374.s001BackgroundPostmenopausal osteoporosis (PMO) is a prevalent metabolic bone disease wherein immune dysregulation and autophagy are critically involved. This study aimed to identify key genes linking immune cells and autophagy in PMO and construct a diagnostic model.MethodsAutophagy-immune-related differentially expressed genes (DEGs) were identified by integrating limma analysis, WGCNA module genes, and autophagy-related genes (ARGs). Hub genes were screened via protein-protein interaction (PPI) network and statistical tests. A diagnostic model was built and validated. Functional enrichment (GSEA) and immune infiltration analysis (GSVA) were performed. Regulatory networks involving transcription factors (TFs) and microRNAs (miRNAs) were constructed. Drug prediction and single-cell RNA sequencing (scRNA-seq) analyses were conducted. An ovariectomized (OVX) mouse model was established to assess bone mineral density, serum biomarkers, and hub gene expression via RT-qPCR.ResultsThree hub genes (CDK2, DDIT3, MAPK8) were identified. The diagnostic model exhibited high predictive accuracy (AUC = 0.91). GSEA indicated CDK2 and DDIT3 were associated with ligand-receptor interaction pathways. Hub genes correlated significantly with altered immune cell infiltration. Regulatory networks included multiple TFs and miRNAs. Drug prediction identified potential therapeutics targeting each hub gene. scRNA-seq highlighted bone marrow mesenchymal stem cells (BM MSCs) as a key site, with pseudotemporal analysis revealing dynamic hub gene expression during differentiation. In vivo, OVX mice showed reduced bone density, estradiol, and osteocalcin, elevated CTX-1, and increased MAPK8 and DDIT3 expression.ConclusionAn immune-autophagy-related diagnostic model based on DDIT3 and MAPK8 was developed and validated, offering new insights into PMO evaluation and therapeutic strategy.
Keyword(s):
autophagy; Cell Metabolism; diagnostic model; immune cell; postmenopausal osteoporosis.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)